Ministry supports conditional use of ganja for research, medicinal purposes

Tuesday, November 20, 2018

Print this page Email A Friend!

CHIEF Medical Officer Dr Jacqueline Bisasor-McKenzie says the Ministry of Health supports the use of cannabis and products derived from the plant for research and medicinal purposes, where scientific evidence validates their benefits and effectiveness in treating specific conditions.

Speaking at a Jamaica Information Service (JIS) Think Tank last Friday, Dr Bisasor-McKenzie said the ministry is prepared to accept or evaluate products that are administered in a particular form.

These, she said, include tinctures, vaping, sublingual drops, topical solutions and capsules made from extracts, adding that the ministry regulates the compounds made from cannabis extracts.

“We are responsible for the safety, consistency and effectiveness of the products that we register,” she explained.

According to the chief medical officer, the products' therapeutic authenticity are validated through studies that are carefully reviewed by the ministry, which, she noted, also monitors distribution and sale of the products by registered providers.

“The prescription or recommendation of these items are by medical professionals who would have been educated about the products and their indications in the same way as any other drug on the market” she said.

This, she added, is imperative, as the industry is highly specialised and requires adherence to specific standards to produce a drug for medicinal use.

Dr Bisasor-McKenzie alluded to the report of the Caricom Regional Commission on Marijuana 2018, which states that access to medical marijuana should be facilitated for qualifying conditions in which there is clear evidence of its therapeutic benefits and for debilitating life-threatening conditions that are intractable to treatment, and where there is evidence of possible benefits.

“These include patients on chemotherapy with nausea and vomiting, glaucoma, asthma, anorexia and weight loss in AIDS, cancers, anorexia nervosa, chronic and neuropathic pain, multiple sclerosis, sleep disorders and some neuropsychiatric disorders” she outlined.

Dr Bisasor-McKenzie said it is also important to note that the amendments to the Dangerous Drug Act, facilitating the use of medicinal marijuana, states that the user must be certified by a registered medical practitioner as suffering from cancer or any other terminal or serious chronic illness, and that the medicinal or therapeutic product is recommended by that registered medical practitioner.

Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at




1. We welcome reader comments on the top stories of the day. Some comments may be republished on the website or in the newspaper � email addresses will not be published.

2. Please understand that comments are moderated and it is not always possible to publish all that have been submitted. We will, however, try to publish comments that are representative of all received.

3. We ask that comments are civil and free of libellous or hateful material. Also please stick to the topic under discussion.

4. Please do not write in block capitals since this makes your comment hard to read.

5. Please don't use the comments to advertise. However, our advertising department can be more than accommodating if emailed:

6. If readers wish to report offensive comments, suggest a correction or share a story then please email:

7. Lastly, read our Terms and Conditions and Privacy Policy

comments powered by Disqus



Today's Cartoon

Click image to view full size editorial cartoon